Cargando…

The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases

BACKGROUND: Rare diseases pose many research challenges specific to their scarcity. Advances in potential therapies have made it more important than ever to be able to adequately identify not only patients with particular genotypes (via patient registries) but also the medical professionals who prov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodger, Sunil, Lochmüller, Hanns, Tassoni, Adrian, Gramsch, Kathrin, König, Kirsten, Bushby, Kate, Straub, Volker, Korinthenberg, Rudolf, Kirschner, Janbernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819466/ https://www.ncbi.nlm.nih.gov/pubmed/24148153 http://dx.doi.org/10.1186/1750-1172-8-171

Ejemplares similares

How reference networks develop, implement, and monitor guidelines
por: Kirschner, Jan, et al.
Publicado: (2012)

Adult care for Duchenne muscular dystrophy in the UK
por: Rodger, Sunil, et al.
Publicado: (2014)

De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany
por: König, Kirsten, et al.
Publicado: (2019)

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development
por: Heslop, Emma, et al.
Publicado: (2015)

European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences
por: Vry, Julia, et al.
Publicado: (2016)

Special Issue “Neuromuscular Disorders in Children and Adolescents”
por: Korinthenberg, Rudolf
Publicado: (2022)

SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy
por: Pechmann, Astrid, et al.
Publicado: (2019)

Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey
por: Schorling, David C., et al.
Publicado: (2020)

Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
por: Ayoglu, Burcu, et al.
Publicado: (2014)

Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis
por: Landfeldt, Erik, et al.
Publicado: (2016)

The Canadian Neuromuscular Disease Registry 2010–2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry
por: Hodgkinson, V., et al.
Publicado: (2021)

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
por: Willmann, Raffaella, et al.
Publicado: (2020)

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
por: Wood, Libby, et al.
Publicado: (2017)

Quantifying the burden of caregiving in Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2016)

Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study
por: Landfeldt, Erik, et al.
Publicado: (2015)

A multi-source approach to determine SMA incidence and research ready population
por: Verhaart, Ingrid E. C., et al.
Publicado: (2017)

Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
por: Landfeldt, Erik, et al.
Publicado: (2020)

The burden of Duchenne muscular dystrophy: An international, cross-sectional study
por: Landfeldt, Erik, et al.
Publicado: (2014)

Compliance to Care Guidelines for Duchenne Muscular Dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2015)

E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019
por: Pini, Jonathan, et al.
Publicado: (2021)

Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
por: Landfeldt, Erik, et al.
Publicado: (2019)

Undiagnosed Genetic Muscle Disease in the North of England: an in Depth Phenotype Analysis
por: Harris, Elizabeth, et al.
Publicado: (2013)

Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy
por: Burch, Peter M., et al.
Publicado: (2015)

Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: “Translating“ the Translational
por: McCormack, Pauline, et al.
Publicado: (2013)

Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
por: Rodger, Sunil, et al.
Publicado: (2012)

Editorial: Molecular Mechanisms Underlying Assembly and Maintenance of the Neuromuscular Junction
por: Herbst, Ruth, et al.
Publicado: (2021)

The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
por: Bladen, Catherine L, et al.
Publicado: (2015)

Improvements in Walking Distance during Nusinersen Treatment – A Prospective 3-year SMArtCARE Registry Study
por: Pechmann, Astrid, et al.
Publicado: (2023)

MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide
por: Reza, Mojgan, et al.
Publicado: (2017)

UK Facioscapulohumeral Muscular Dystrophy (FSHD) Patient Registry
por: Wood, Libby, et al.
Publicado: (2014)

Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9
por: Murphy, Lindsay B., et al.
Publicado: (2020)

Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer
por: Sernadela, Pedro, et al.
Publicado: (2017)

Standards of care in neuromuscular fields
por: Straub, Volker
Publicado: (2013)

Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
por: Koeks, Zaïda, et al.
Publicado: (2017)

A Registry for Evaluation of Efficiency and Safety of Surgical Treatment of Cartilage Defects: The German Cartilage Registry (KnorpelRegister DGOU)
por: Maurer, Julia, et al.
Publicado: (2016)

Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
por: Chiu, Yen-Hui, et al.
Publicado: (2009)

New aspects on patients affected by dysferlin deficient muscular dystrophy
por: Klinge, Lars, et al.
Publicado: (2009)

Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
por: O’Connor, Kaela, et al.
Publicado: (2023)

Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR)
por: Roy, Anna J., et al.
Publicado: (2014)

Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study
por: Peterlin, Borut, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uec2522dimc5t435va8265v7p2